Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer, Hematological”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05005442
What this trial is testing

Pembrolizumab/Vibostolimab (MK-7684A) in Relapsed/Refractory Hematological Malignancies (MK-7684A-004, KEYVIBE-004)

Who this might be right for
Hematological Malignancies
Merck Sharp & Dohme LLC 192
Not applicableNot Yet RecruitingNCT07607379
What this trial is testing

Robotic Dog Intervention on Emotional Well-Being and Quality of Life

Who this might be right for
Emotional Well-beingQuality of LifePediatric Oncology
Koç University 28
Post-approval studies (Phase 4)UnknownNCT01339988
What this trial is testing

Busulfan and Cyclophosphamide Instead of Total Boby Irradiation (TBI) and Cyclophosphamide for Hematological Malignancies Hematocrit (HCT)

Who this might be right for
Acute LeukemiasChronic LeukemiasMyelodysplastic Syndrome+1 more
Tel-Aviv Sourasky Medical Center 10
Not applicableLooking for participantsNCT06125483
What this trial is testing

TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT

Who this might be right for
Hematopoietic MalignancyRelapse/RecurrenceHematopoietic Stem Cell Transplantation
The First Affiliated Hospital of Soochow University 38
Early research (Phase 1)Study completedNCT05391022
What this trial is testing

Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies

Who this might be right for
Advanced MalignanciesSolid TumorHematological Malignancy
Constellation Pharmaceuticals 35
Not applicableStudy completedNCT01714180
What this trial is testing

Effect of Body Mass on Acyclovir Pharmacokinetics

Who this might be right for
Hematological MalignancyPharmacokinetics of Acyclovir
West Virginia University 14
Testing effectiveness (Phase 2)WithdrawnNCT03739606
What this trial is testing

Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center
Early research (Phase 1)Study completedNCT04184869
What this trial is testing

Extension Study for Patients Who Had Not Met Criteria for Discontinuation in Previous Sponsored Belinostat Trials

Who this might be right for
Solid TumorHematological Malignancies
Acrotech Biopharma Inc. 8
Testing effectiveness (Phase 2)Study completedNCT01930162
What this trial is testing

Safety and Tolerability of HSC835 in Patients With Hematological Malignancies Undergoing Single Umbilical Cord Blood Transplant

Who this might be right for
Single Umbilical Cord Blood TransplantationNon-myeloablative ConditioningAcute Lymphocytic Leukemia+4 more
Novartis Pharmaceuticals 9
Early research (Phase 1)Study completedNCT00780052
What this trial is testing

Infusional C-myb ASODN in Advanced Hematologic Malignancies

Who this might be right for
Hematologic Malignancies
Abramson Cancer Center at Penn Medicine 13
Not applicableNot Yet RecruitingNCT07047352
What this trial is testing

Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)

Who this might be right for
Carbapenem-resistant EnterobacteralesNeutropeniaHematological Malignancies
Shanghai Jiao Tong University School of Medicine 91
Early research (Phase 1)Ended earlyNCT00963495
What this trial is testing

Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological Malignancy

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+4 more
University Health Network, Toronto 11
Post-approval studies (Phase 4)Ended earlyNCT02895529
What this trial is testing

A Study Comparing the Efficacy of Intravenous Followed by Oral Itraconazole With Intravenous Caspofungin For Empiric Antifungal Therapy in Neutropenic Participants With Hematological Malignancy

Who this might be right for
Hematologic Neoplasms
Xian-Janssen Pharmaceutical Ltd. 61
Early research (Phase 1)Looking for participantsNCT07572006
What this trial is testing

JNJ-95804306 for Relapsed or Refractory Hematological Malignancies

Who this might be right for
Hematologic Neoplasms
Janssen Research & Development, LLC 360
Not applicableStudy completedNCT01799421
What this trial is testing

Risk Assessment of Febrile Neutropenia and Grade 3-4 Neutropenia in Patients With Non-hematological Cancer Treated With Conventional Chemotherapy

Who this might be right for
Non-hematologic Cancer
Asociación para el Fomento de la Investigación y el Desarrollo Integral de la Oncología 420
Very early researchUnknownNCT04184414
What this trial is testing

The Clinical Application of Chimeric Antigen Receptor T Cells in the Treatment of CD19 Positive Recurrent Refractory B Cell-derived Hematological Malignancies

Who this might be right for
B Acute Lymphoblastic LeukemiaMantle Cell LymphomaFollicular Lymphoma
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Early research (Phase 1)Not Yet RecruitingNCT07809906
What this trial is testing

Study of ORM-1153 in Acute Myeloid Leukemia (AML) With CD123 Expression

Who this might be right for
CD123+ Acute Myeloid Leukemia
Orum Therapeutics USA, Inc. 42
Post-approval studies (Phase 4)Study completedNCT02966457
What this trial is testing

DEcolonization in Patients With HAematological Malignancies (DEHAM)

Who this might be right for
Hematological Infection
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology 62
Early research (Phase 1)Study completedNCT00660920
What this trial is testing

Safety Study of AP24534 to Treat Chronic Myelogenous Leukemia (CML) and Other Hematological Malignancies

Who this might be right for
Chronic Myelogenous LeukemiaHematologic Malignancies
Ariad Pharmaceuticals 81
Not applicableNot Yet RecruitingNCT07525024
What this trial is testing

KSD-101 in Patients With EBV-associated Hematological Malignancies

Who this might be right for
EBV Associated Lymphoid Neoplasms
Ruijin Hospital 80
Next Page